Meeting
2023 ASCO Annual Meeting
Risk stratification tools to help decide on adjuvant chemotherapy usage in resected soft tissue sarcomas: A 10 year review of an Irish sarcoma centre experience.
Authors
Catherine Weadick
Department of Medical Oncology, Cork University Hospital, Cork, Ireland
Catherine Weadick , Rachel J Keogh , Caitriona Goggin , Jake Murphy , Linda Feeley , Michael William Bennett , Seamus O'Reilly , Henry Paul Redmond , Jason Kelly , Deirdre O'Mahony , Sinead Noonan , Jim Clover , Richard Martin Bambury
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 11575)
DOI
10.1200/JCO.2023.41.16_suppl.11575
Abstract #
11575
Poster Bd #
509
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Number of prescription medications and overall survival in veterans with metastatic hormone-sensitive prostate cancer.
First Author: Krishny Karunanandaa
Poster
2018 ASCO Annual Meeting
Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931.
First Author: Sandro Pasquali
Poster
2013 ASCO Annual Meeting
Prospective comparison of uPA/PAI-1 and endopredict-clin score in ER-positive, HER2-negative breast cancer: Impact on risk stratification and treatment decisions.
First Author: Johannes Ettl
Poster
2024 ASCO Annual Meeting
A potential novel therapeutic target for invasive soft tissue sarcoma detected through tumor immune microenvironment and genetic profile analyses.
First Author: Akane Ariga